PAX3 and melanoma: Phosphorylated STAT3 transcriptionally activates PAX3 expression in melanocytes, and the silencing of STAT3 or PAX3 using RNAi was recently shown to inhibit the growth of melanoma cells, particularly in melanoma cells that have acquired resistance to the BRAF inhibitor, vemurafenib (24).